Osaic Holdings’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Osaic Holdings’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24	Closed	-$14	–	7697
2023 Q1	$14	Hold	24	–	–	﹤0.01%	7440
2022 Q4	$0	Hold	24	–	–	﹤0.01%	7600
2022 Q3	$0	Buy	+24	New	+$91	﹤0.01%	7663
2021 Q4	–	Sell	-80	Closed	-$1K	–	7700
2021 Q3	$1K	Hold	80	–	–	﹤0.01%	7126
2021 Q2	$1K	Hold	80	–	–	﹤0.01%	6932
2021 Q1	$2K	Hold	80	–	–	﹤0.01%	6554
2020 Q4	$1K	Sell	80 -7	-8%	-$103	﹤0.01%	6322
2020 Q3	$2K	Buy	87 +60	+222%	+$1.13K	﹤0.01%	5926
2020 Q2	$0	Sell	27 -16	-37%	-$250	﹤0.01%	6419
2020 Q1	$1K	Buy	+43	New	+$873	﹤0.01%	5972

Other funds holding VYNT

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Osaic Holdings's VYNT Position: Q2 2023 in Review

Osaic Holdings sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2023, closing a stake of 24 shares — an estimated $14 sold.

Osaic Holdings first reported a position in VYNT in Q1 2020 and held it in 10 quarters. The position peaked at $2K in Q1 2021. 1 fund tracked by Wall St. Rank holds VYNT as of Q2 2023.

Osaic Holdings reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Osaic Holdings sold 24 Vyant Bio, Inc. Common Stock shares in Q2 2023, an estimated $14.
Osaic Holdings first reported a position in Vyant Bio, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
Osaic Holdings's Vyant Bio, Inc. Common Stock position peaked at $2K in Q1 2021.
1 fund tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2023.

Based on Osaic Holdings's 13F filing for Q2 2023, filed 10 Aug 2023.